Cargando…
Renal Complications Related to Checkpoint Inhibitors: Diagnostic and Therapeutic Strategies
Immune checkpoint inhibitors (ICI) targeting CTLA-4 and the PD-1/PD-L1 axis have unprecedentedly improved global prognosis in several types of cancers. However, they are associated with the occurrence of immune-related adverse events. Despite their low incidence, renal complications can interfere wi...
Autores principales: | Belliere, Julie, Mazieres, Julien, Meyer, Nicolas, Chebane, Leila, Despas, Fabien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303282/ https://www.ncbi.nlm.nih.gov/pubmed/34208848 http://dx.doi.org/10.3390/diagnostics11071187 |
Ejemplares similares
-
Acute interstitial nephritis related to immune checkpoint inhibitors
por: Belliere, Julie, et al.
Publicado: (2016) -
Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors
por: Benyahia, Rayane, et al.
Publicado: (2023) -
When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
por: Mhanna, Laurent, et al.
Publicado: (2019) -
Drug–drug interactions with imatinib: An observational study
por: Récoché, Isabelle, et al.
Publicado: (2016) -
‘Prevention is better than cure’: warning for comedications in patients receiving immune checkpoint inhibitors to avoid acute kidney injury
por: Belliere, Julie, et al.
Publicado: (2022)